about
Safety and efficacy of co-trimoxazole for treatment and prevention of Plasmodium falciparum malaria: a systematic reviewPrevalence of the dhfr and dhps Mutations among Pregnant Women in Rural Burkina Faso Five Years after the Introduction of Intermittent Preventive Treatment with Sulfadoxine-PyrimethamineHigh-level Plasmodium falciparum sulfadoxine-pyrimethamine resistance with the concomitant occurrence of septuple haplotype in TanzaniaGlucose-6-phosphate dehydrogenase deficiency, chlorproguanil-dapsone with artesunate and post-treatment haemolysis in African children treated for uncomplicated malariaSafety of daily co-trimoxazole in pregnancy in an area of changing malaria epidemiology: a phase 3b randomized controlled clinical trialRanking malaria risk factors to guide malaria control efforts in African highlands.The World Bank: false financial and statistical accounts and medical malpractice in malaria treatment.Antimicrobial-resistant infections among postpartum women at a Ugandan referral hospital.Intermittent preventive treatment: efficacy and safety of sulfadoxine-pyrimethamine and sulfadoxine-pyrimethamine plus piperaquine regimens in schoolchildren of the Democratic Republic of Congo: a study protocol for a randomized controlled trial.Artemisinin-based combination therapy in pregnant women in Zambia: efficacy, safety and risk of recurrent malariaDefining the malaria burden in Nchelenge District, northern Zambia using the World Health Organization malaria indicators surveySevere malaria not responsive to artemisinin derivatives in man returning from Angola to Vietnam.Pharmacokinetics of co-formulated mefloquine and artesunate in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum infection in Burkina Faso.Exposure to Phlebotomus argentipes (Diptera, Psychodidae, Phlebotominae) sand flies in rural areas of Bihar, India: the role of housing conditions.Interactions between malaria and human immunodeficiency virus anno 2014Malaria, schistosomiasis and soil transmitted helminth burden and their correlation with anemia in children attending primary schools in Kinshasa, Democratic Republic of CongoFour Artemisinin-Based Treatments in African Pregnant Women with Malaria.Plasmodium falciparum strains harboring dihydrofolate reductase with the I164L mutation are absent in Malawi and Zambia even under antifolate drug pressureSafety and efficacy of dihydroartemisinin-piperaquine versus artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Zambian children.High prevalence of Schistosoma mansoni in six health areas of - Kasansa health zone, Democratic Republic of the Congo: short report.Disease diagnosis in primary care in UgandaIn vivo selection of Plasmodium falciparum Pfcrt and Pfmdr1 variants by artemether-lumefantrine and dihydroartemisinin-piperaquine in Burkina Faso.Safe and efficacious artemisinin-based combination treatments for African pregnant women with malaria: a multicentre randomized control trialExposure to artemether-lumefantrine (Coartem) in first trimester pregnancy in an observational study in ZambiaThe relationship between Plasmodium infection, anaemia and nutritional status in asymptomatic children aged under five years living in stable transmission zones in Kinshasa, Democratic Republic of Congo.The gametocytocidal efficacy of primaquine in malaria asymptomatic carriers treated with dihydroartemisinin-piperaquine in The Gambia (PRINOGAM): study protocol for a randomised controlled trialMolecular-based isothermal tests for field diagnosis of malaria and their potential contribution to malaria elimination.The perceptions and perspectives of patients and health care providers on chronic diseases management in rural South Africa: a qualitative study.Placental Plasmodium falciparum malaria infection: operational accuracy of HRP2 rapid diagnostic tests in a malaria endemic setting.Barriers to Condom Use among High Risk Men Who Have Sex with Men in Uganda: A Qualitative Study.Artemether-Lumefantrine Combination Therapy for Treatment of Uncomplicated Malaria: The Potential for Complex Interactions with Antiretroviral Drugs in HIV-Infected Individuals.Ex vivo anti-malarial drug susceptibility of Plasmodium falciparum isolates from pregnant women in an area of highly seasonal transmission in Burkina FasoCapacity of Health Facilities to Manage Hypertension in Mukono and Buikwe Districts in Uganda: Challenges and Recommendations.Population Genetics of Plasmodium vivax in the Peruvian AmazonThe Prevalence and Determinants of Chronic Non-Communicable Disease Risk Factors amongst Adults in the Dikgale Health Demographic and Surveillance System (HDSS) Site, Limpopo Province of South AfricaUncomplicated Clinical Malaria Features, the Efficacy of Artesunate-Amodiaquine and Their Relation with Multiplicity of Infection in the Democratic Republic of Congo.Combination Treatment for Visceral Leishmaniasis Patients Coinfected with Human Immunodeficiency Virus in IndiaEffectiveness of educational outreach in infectious diseases management: a cluster randomized trial in Uganda.Puerperal sepsis, the leading cause of maternal deaths at a Tertiary University Teaching Hospital in Uganda.Diagnostic performance of a novel loop-mediated isothermal amplification (LAMP) assay targeting the apicoplast genome for malaria diagnosis in a field setting in sub-Saharan Africa.
P50
Q21133667-FBFA01D6-1448-4FC4-8B3E-F59AE1FC88D6Q28125923-D25EDBCE-F113-476B-B829-F223F5EE871BQ28125930-96BD6D3F-21DA-4002-8621-CE6C7EEB0454Q28265711-AD4D860A-4E54-40B9-AB8F-F4FEA8FE2675Q28538874-B1370466-F3BA-4F2E-B37C-A699774BC45AQ30928214-F07C3379-8227-4D25-8E57-90A5BEA5C51BQ33449564-180EC1FA-6E17-4C3A-8FAF-CEAF7AEAABA9Q33562883-E868C6D3-D45D-48F6-9768-DC193E271E31Q33589334-5C8D42F4-A2BC-49F6-9435-56F18934E5A3Q33696767-3CF62282-4292-4545-93BE-75E9CBBCD737Q33793729-4116A6B9-B2EB-483E-86B7-7856DA8A352DQ33816332-EA20C1E1-163C-447D-8FAD-24FE261D0B9FQ34034413-862B18FB-4479-49E0-9231-DC35619EEF94Q34129087-EDA00197-370B-4607-804F-866672BBDD8DQ34404275-B74C1BAD-0F18-4FD0-B0FF-93F454C21851Q34456040-6D536742-F6FF-48A5-A478-C8C9C5B65F7EQ34517634-51164C6C-3617-466A-83E2-184355F83B11Q34657000-C0DEF372-0640-456B-B51F-E75A54DAB5ECQ34662803-757D3175-8B71-4F80-BE54-4B4DB89EEED1Q34734114-956F1376-A119-4821-81CE-2CC8E99B4E7AQ34887899-6205A11C-2C4B-4792-9D27-43460525755DQ34923315-68001E2E-ABFA-4D3B-B358-0CB7C84E39E6Q35078624-70D98261-1E10-4B89-BCD3-31A2D61BB5C2Q35108464-D34BB6C0-E8B0-4583-AAA7-1BAE230BB170Q35108578-26BF8187-3B90-4AE1-8D27-C6D4BD3B94FDQ35147721-8464CCB0-CB61-46A8-B6ED-BA39F612F80BQ35253767-BDE6A704-B6E9-4742-A842-739D155171AFQ35443340-C9A213E1-4285-46A9-9FB8-0FD8E2A53F51Q35505497-A382A6E8-5DF1-4F19-AE14-77A0A0E79C9DQ35690740-E70EA7A9-566D-48B7-8DC4-E1BB0C40F72DQ35692270-7C8F28FA-7C51-4B70-83AF-1382AC211850Q35760573-271CE184-EA5E-42AD-991E-B9D481501D22Q35839050-52EC7A69-5991-413C-931D-A0EC7FA6A5D2Q35894048-061C75F8-B92E-4D1B-AF3C-F4EAF1B65C89Q35924997-9F782114-E8CC-4891-978D-32522FDA68C4Q36046765-DC023C71-B204-4A75-B38A-7730B6C712B6Q36094248-00CF7356-2639-4750-A3F5-910FA60970E2Q36094449-960AA20D-9937-49C7-9FB5-99FE4F68EB2EQ36096430-BC646717-34E2-4626-8283-F4BF73F5ABABQ36141058-54AB8D65-63D1-4E78-85E5-2820B32C43F4
P50
description
researcher ORCID ID = 0000-0001-5006-6364
@en
wetenschapper
@nl
name
Jean-Pierre Van Geertruyden
@ast
Jean-Pierre Van Geertruyden
@en
Jean-Pierre Van Geertruyden
@es
Jean-Pierre Van Geertruyden
@nl
type
label
Jean-Pierre Van Geertruyden
@ast
Jean-Pierre Van Geertruyden
@en
Jean-Pierre Van Geertruyden
@es
Jean-Pierre Van Geertruyden
@nl
prefLabel
Jean-Pierre Van Geertruyden
@ast
Jean-Pierre Van Geertruyden
@en
Jean-Pierre Van Geertruyden
@es
Jean-Pierre Van Geertruyden
@nl
P21
P31
P496
0000-0001-5006-6364